Lundbeckfond Invest A/S has filed 5 insider transactions across 1 company since November 2023.
Most recent transaction: a transaction of 1321474 shares of Lexeo Therapeutics, Inc. ($LXEO) on November 07, 2023.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 7, 2023 | Lexeo Therapeutics, Inc. | $LXEO | Lundbeckfond Invest A/S | TenPercentOwner | C | Common Stock | 1321474 | $0.00 | 1,321,474.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2023 | Lexeo Therapeutics, Inc. | $LXEO | Lundbeckfond Invest A/S | TenPercentOwner | C | Common Stock | 287213 | $0.00 | 1,608,687.0000 | 0 | 21.73% | 0.00% |
| Nov. 7, 2023 | Lexeo Therapeutics, Inc. | $LXEO | Lundbeckfond Invest A/S | TenPercentOwner | P | Common Stock | 227272 | $11.00 | 1,835,959.0000 | 0 | 14.13% | 0.00% |
| Nov. 7, 2023 | Lexeo Therapeutics, Inc. | $LXEO | Lundbeckfond Invest A/S | TenPercentOwner | C | Series A convertible preferred stock | 13999999 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2023 | Lexeo Therapeutics, Inc. | $LXEO | Lundbeckfond Invest A/S | TenPercentOwner | C | Series B convertible preferred stock | 2615533 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |